Effects on All-cause Mortality and Cardiovascular Outcomes in Patients With Type 2 Diabetes by Comparing Insulin With Oral Hypoglycemic Agent Therapy: A Meta-analysis of Randomized Controlled Trials-Reference-Cited by-同舟云学术

Effects on All-cause Mortality and Cardiovascular Outcomes in Patients With Type 2 Diabetes by Comparing Insulin With Oral Hypoglycemic Agent Therapy: A Meta-analysis of Randomized Controlled Trials

Published:2016-02 Issue:2 Volume:38 Page:372-386.e6
ISSN:0149-2918
Container-title:Clinical Therapeutics
language:en
Short-container-title:Clinical Therapeutics

Author:

Li Juan,Tong Yuzhen,Zhang Yuwei,Tang Lizhi,LV Qingguo,Zhang Fang,Hu Ruijie,Tong Nanwei

Publisher

Elsevier BV

Subject

Pharmacology (medical),Pharmacology

Reference44 articles.

1. Global estimates of diabetes prevalence for 2013 and projections for 2035;Guariguata;Diabetes Res Clin Pract,2013

2. Effect of intensive glucose lowering treatment on all cause mortality, cardiovascular death, and microvascular events in type 2 diabetes: meta-analysis of randomised controlled trials;Boussageon;BMJ,2011

3. Mortality risk with sulphonylureas compared to metformin;Holden;Diabetes Obes Metab,2014

4. Insulin use and increased risk of mortality in type 2 diabetes: a cohort study;Gamble;Diabetes Obes Metab,2010

5. Mortality and other important diabetes-related outcomes with insulin vs other antihyperglycemic therapies in type 2 diabetes;Currie;J Clin Endocrinol Metab,2013

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Carnosine supplementation improves glucose control in adults with pre-diabetes and type 2 diabetes: A randomised controlled trial;Nutrition, Metabolism and Cardiovascular Diseases;2023-10

2. Risk of heart failure in patients with type 2 diabetes receiving insulin therapy: a meta-analysis of observational studies;Russian Journal of Cardiology;2023-04-15

3. Carnosine supplementation improves glucose control in adults with pre-diabetes and type 2 diabetes: a randomised controlled trial;2023-03-23

4. Tirzepatide versus insulin glargine in type 2 diabetes and increased cardiovascular risk (SURPASS-4): a randomised, open-label, parallel-group, multicentre, phase 3 trial;The Lancet;2021-11

5. Effects of Postoperative Percutaneous Coronary Intervention, Pharmacologic Treatment, and Predisposing Factors on Clinical Outcomes in Patients With and Without Type 2 Diabetes Along With Critical Limb Ischemia;Clinical Therapeutics;2021-01